(NYSE MKT:AIM), OCALA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing Ampligen(R) (rintatolimod) was accepted in a late-breaking abstract at the 40th Annual SITC Meeting being held November 5-9, […]

(NasdaqGM:USIO), SAN ANTONIO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq:USIO), a leading provider of integrated, cloud-based electronic payment and embedded financial solutions, today announced record processing and transaction volumes across virtually all of its businesses for the three months ended September 30, 2025. Usio, Inc. President and CEO Louis Hoch, noted, that for

Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting GlobeNewswire November 04, 2025 CR-001 Demonstrated Cooperative Pharmacology and Robust Anti-Tumor Activity IND Submission for CR-001 On Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1

CERo Therapeutics to Present Data at the Society for Immunotherapy of Cancer Conference Highlighting Lead Compound CER-1236 Sustained Cell Expansion and Cytokine Response GlobeNewswire November 04, 2025 Newly released preclinical data to be presented in a poster on November 8, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — CERo Therapeutics Holdings, Inc.,

AIM ImmunoTech Announces Late Breaking Abstract from University of Pittsburgh Medical Center Accepted for Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting GlobeNewswire November 04, 2025 OCALA, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data from the completed

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia GlobeNewswire November 04, 2025 MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ:

Claire's Place Foundation & Buffalo Exchange Host Fundraising Pop-Up Featuring Actor Haley Lu Richardson's Clothing Special Sweepstakes offers fans a chance to win Haley Lu's iconic crocheted sweater from Five Feet Apart GlobeNewswire November 04, 2025 Los Angeles, CA, Nov. 04, 2025 (GLOBE NEWSWIRE) — Claire's Place Foundation, a nonprofit organization providing support to children

Usio Reports Record Third Quarter 2025 Processing Volumes Widespread Growth Across Many Key Processing and Volume Metrics Reflects Strong Receptivity to Company's Diversified Market Strategy GlobeNewswire November 04, 2025 SAN ANTONIO, Nov. 04, 2025 (GLOBE NEWSWIRE) — Usio, Inc. (Nasdaq:USIO), a leading provider of integrated, cloud-based electronic payment and embedded financial solutions, today announced record

Today, LOAM, a biotechnology company building the next generation of microbiome support, introduces a revolutionary advancement in gut health with the launch of their first product – Prebiotic Fiber Formula. With a nearly 40,000 person waitlist, and founded byphysician Dr. Karan Rajan – a leading global voice in health and wellness – LOAM is a

Products are designed to address the unique challenges faced by hybrid engines, like frequent stop-start wear and moisture build-up, offering advanced protection where traditional additives fall short Lucas Oil, the nation's top-selling brand in oil additives and performance lubricants, today announced the launch of its first-ever product line designed exclusively for hybrid vehicles: Hybrid Oil